Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Verastem completes $20.1mm Series C round

Executive Summary

Just prior to filing for its initial public offering, cancer drug discovery start-up Verastem Inc. raised $20.1mm through its Series C round. New investor Eastern Capital led with a $9mm contribution, and was joined by returning backers CHP (managed by Cardinal Partners), Longwood Founders Fund, MPM Bioventures, Bessemer Venture Partners, Advanced Technology Ventures, and 28 additional investors.
Deal Industry
  • Pharmaceuticals
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies